The COVID-19 crisis is a worldwide emergency, and you may understandably feel worried about the impact of coronavirus on you and your loved ones—especially if you have a chronic condition like hypothyroidism or Hashimoto's thyroiditis. It's important to us for our community to have the most up-to-date information.
Am I at higher risk?
There is no available data to suggest that patients with hypothyroidism or Hashimoto's are at higher risk of COVID-19. Patients with hypothyroidism or Hashimoto's should maintain thyroid treatment as in normal times.
Read our full analysis here:
Coronavirus and Hashimoto's
Comprehensive primer about what thyroid patients need to know about novel coronavirus, COVID-19.
Older populations or those with compromised immune systems are most at risk
Symptoms
Fever above 100.4F
Cough
Shortness of breath
Presenting 2-14 days after exposure
Transmission
Transmitted via respiratory droplets (coughs and sneezes)
Virus droplets may persist on surfaces
People may be contagious before symptoms appear
When should I be concerned?
General concern for COVID is low unless you or someone in your household have:
Fever +/- Cough + Exposure
This means there are signs of illness (fever or respiratory problems including cough, wheezing, or trouble breathing) AND you’ve come in contact with someone known to have the virus or someone in an area where the virus is circulating who’s displaying the symptoms above.
Fever + Cough + Travel
This means there are signs of illness (fever AND respiratory problems including cough, wheezing, or trouble breathing) AND you have traveled to an area known to have community transmission within the last 14 days.
Fever + Severe Respiratory Illness + Hospitalization
This means you have a fever with severe lower respiratory illness, such as pneumonia, requiring admission to a hospital or intensive care unit.
Paloma Health is thyroid care done differently. Top rated thyroid doctors empowered by advanced technology deliver preventive, personalized care to our patients anytime, anywhere.